SCHEMBL1572912

SCHEMBL1572912

C=C(C)COP(=O)(CC)C(CO)[N+](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL80349 0.76 TSHR (0.33)
SCHEMBL7775047 0.74 BTN3A1 (0.30)
SCHEMBL1260407 0.70 TSHR (0.33)
SCHEMBL22973394 0.67
SCHEMBL4820864 0.67 BTN3A1 (0.35)
SCHEMBL17076358 0.66 TSHR (0.36)
SCHEMBL4822138 0.65 BTN3A1 (0.34)
SCHEMBL6278176 0.65 THRB (0.33)
SCHEMBL418513 0.64 TSHR (0.41)
SCHEMBL17076362 0.62 TSHR (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170708-B1 OPHTHALMIC SOLUTIONS BAUSCH & LOMB (US) 2012-10-24 EP claimed
EP-1314982-B1 HIGHLY REPRODUCIBLE AGGLUTINATION IMMUNOASSAY METHOD AND REAGENTS KYOWA MEDEX CO LTD (JP) 2009-07-29 EP claimed
US-20030170313-A1 Micro-particulate and nano-particulate polymeric delivery system VANDERBILT UNIVERSITY 2003-09-11 US claimed
US-20250319280-A1 CORRUGATED CATHETERS PERFUZE LIMITED (IE) 2025-10-16 US disclosed
EP-4613215-A2 IMPROVEMENTS IN CORRUGATED CATHETERS Perfuze Limited (IE) 2025-09-10 EP disclosed
EP-3986519-B1 IMPROVEMENTS IN CORRUGATED CATHETERS PERFUZE LTD (IE) 2025-09-03 EP disclosed
US-12239797-B2 Corrugated catheters PERFUZE LIMITED (IE) 2025-03-04 US disclosed
CN-118546284-A High-strength zwitterionic double-network hydrogel and preparation method and application thereof 台州学院 2024-08-27 CN disclosed
CN-116847870-A Improvement of physical and psychological health in patients with hypoparathyroidism 阿森迪斯药物骨疾病股份有限公司 2023-10-03 CN disclosed
CN-114828904-B Method for manufacturing medical device 东丽株式会社 2022-11-29 CN disclosed
US-20220233814-A1 IMPROVEMENTS IN CORRUGATED CATHETERS PERFUZE LIMITED (IE) 2022-07-28 US disclosed
US-20120226236-A1 MEDICAMENT APPLICATION ADAPTER COMPRISING A GAS BLOCKING ELEMENT FOR A HEMODIALYSIS TUBE SET FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (DE) 2012-09-06 US disclosed
WO-2011054497-A1 MEDICAMENT APPLICATION ADAPTER COMPRISING A GAS BLOCKING ELEMENT FOR A HEMODIALYSIS TUBE SET FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH (DE) 2011-05-12 WO disclosed
EP-1590065-B1 FILTER FOR THE SEPARATION OF LEUKOCYTES FROM WHOLE BLOOD OR BLOOD PREPARATIONS, METHOD FOR PRODUCTION OF SAID FILTER, CORRESPONDING DEVICE AND USE THEREOF FRESENIUS HEMOCARE ITALIA S R L (IT) 2011-04-13 EP disclosed
US-20100151188-A1 STRUCTURE HAVING ORGANIC-INORGANIC COMPOSITE LAYER AND METHOD OF MANUFACTURING THE SAME FUJIFILM CORPORATION (JP) 2010-06-17 US disclosed
US-20090239381-A1 POROUS FILM FUJIFILM CORPORATION (JP) 2009-09-24 US disclosed
WO-2008023872-A1 ANTI-FOULING COPOLYMERS RESIN INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) 2008-02-28 WO disclosed
EP-1590065-A1 FILTER FOR THE SEPARATION OF LEUKOCYTES FROM WHOLE BLOOD OR BLOOD PREPARATIONS, METHOD FOR PRODUCTION OF SAID FILTER, CORRESPONDING DEVICE AND USE THEREOF Fresenius Hemocare Italia S.r.l. (IT) 2005-11-02 EP disclosed
WO-2004064980-A1 FILTER FOR THE SEPARATION OF LEUKOCYTES FROM WHOLE BLOOD OR BLOOD PREPARATIONS, METHOD FOR PRODUCTION OF SAID FILTER, CORRESPONDING DEVICE AND USE THEREOF FRESENIUS HEMOCARE ITALIA S.R.L. (IT) 2004-08-05 WO disclosed
US-20030170313-A1 Micro-particulate and nano-particulate polymeric delivery system VANDERBILT UNIVERSITY 2003-09-11 US disclosed